Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1618-1625.e7. doi: 10.1016/j.cgh.2019.11.018. Epub 2019 Nov 9.
BACKGROUND & AIMS: The EncephalApp Stroop test is a high-sensitivity but low-specificity test that has been used to identify patients with covert hepatic encephalopathy (CHE). We aimed to develop a new strategy to detect CHE, combining EncephalApp Stroop test score with scores from subtests of the psychometric hepatic encephalopathy scoring system (PHES).
We performed a survey of 569 adult volunteers (229 men) in 9 communities in Shanghai, China, administering the EncephalApp Stroop test to determine the range of scores in the general population. Data from the standard PHES, including the number connection test-A, number connection test-B (NCT-B), line tracing test, serial dotting test (SDT), and digit symbol test, were used as the reference standard for diagnosis of CHE. A combination of the EncephalApp Stroop with subtests of the PHES was used to establish a new strategy for CHE diagnosis. We validated our findings using data from 160 patients with cirrhosis from 5 centers China.
We determined the range of EncephalApp Stroop test scores for the volunteers of different decades of age, education levels, and sexes. Age, education level, and sex were independently associated with EncephalApp Stroop test scores. A combination of scores from the EncephalApp Stroop test, the NCT-B, and the SDT identified patients with CHE with the highest level of accuracy, when the standard PHES was used as the reference standard. A combination of scores of 187 sec for the EncephalApp Stroop test and below -1 for the NCT-B or below -1 for the SDT identified patients with CHE with an area under the curve (AUC) of 0.86, 81.0% sensitivity, and 91.9% specificity, and 87.5% accuracy. In the validation cohort, these cutoff scores identified patients with CHE with an AUC of 0.88, 97.1% sensitivity, 79.3% specificity, and 86.9% accuracy. The average time to calculate this score was 374±140 sec, compared 424±115 sec for the entire PHES.
Scores from the EncephalApp Stroop test, NCT-B, and SDT identify patients with CHE with approximately 87% accuracy, and in a much shorter time than the standard PHES. This score combination could be a valid and convenient method for identifying patients with CHE. chictr.org.cn number, ChiCTR-EDC-17012007, ChiCTR1800019954.
EncephalApp Stroop 测试是一种高灵敏度但特异性低的测试,已被用于识别隐匿性肝性脑病(CHE)患者。我们旨在开发一种新策略来检测 CHE,将 EncephalApp Stroop 测试评分与心理生理肝性脑病评分系统(PHES)的子测试评分相结合。
我们对中国上海 9 个社区的 569 名成年志愿者(229 名男性)进行了一项调查,对 EncephalApp Stroop 测试进行了测试,以确定一般人群的评分范围。标准 PHES 的数据,包括数字连接测试-A、数字连接测试-B(NCT-B)、连线测试、连续打点测试(SDT)和数字符号测试,被用作 CHE 诊断的参考标准。使用 EncephalApp Stroop 与 PHES 的子测试相结合的组合来建立 CHE 诊断的新策略。我们使用来自中国 5 个中心的 160 名肝硬化患者的数据验证了我们的发现。
我们确定了不同年龄、教育水平和性别的志愿者的 EncephalApp Stroop 测试评分范围。年龄、教育水平和性别与 EncephalApp Stroop 测试评分独立相关。当标准 PHES 作为参考标准时,EncephalApp Stroop 测试、NCT-B 和 SDT 的评分组合可准确识别 CHE 患者。EncephalApp Stroop 测试评分 187 秒以下,NCT-B 评分低于-1 或 SDT 评分低于-1,可识别 CHE 患者,曲线下面积(AUC)为 0.86,敏感性为 81.0%,特异性为 91.9%,准确率为 87.5%。在验证队列中,这些截止分数识别 CHE 患者的 AUC 为 0.88、敏感性为 97.1%、特异性为 79.3%、准确率为 86.9%。计算此分数的平均时间为 374±140 秒,而整个 PHES 为 424±115 秒。
EncephalApp Stroop 测试、NCT-B 和 SDT 的评分可识别 CHE 患者,准确率约为 87%,且耗时明显短于标准 PHES。这种评分组合可能是一种有效且方便的识别 CHE 患者的方法。chictr.org.cn 编号,ChiCTR-EDC-17012007,ChiCTR1800019954。